Cargando…
HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
High-grade diffuse gliomas (HGG) in early childhood are characterized by a more favorable outcome compared to older children. We demonstrated in previous studies that these tumors have stable genomes. Activating tyrosine kinase gene fusions in infant-type hemispheric gliomas represent therapeutic ta...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164882/ http://dx.doi.org/10.1093/neuonc/noac079.236 |
_version_ | 1784720250755874816 |
---|---|
author | Pietsch, Torsten Gielen, Gerrit Waha, Andreas Doerner, Evelyn von Bueren, Andre O Vokuhl, Christian Kristiansen, Glen Kramm, Christof |
author_facet | Pietsch, Torsten Gielen, Gerrit Waha, Andreas Doerner, Evelyn von Bueren, Andre O Vokuhl, Christian Kristiansen, Glen Kramm, Christof |
author_sort | Pietsch, Torsten |
collection | PubMed |
description | High-grade diffuse gliomas (HGG) in early childhood are characterized by a more favorable outcome compared to older children. We demonstrated in previous studies that these tumors have stable genomes. Activating tyrosine kinase gene fusions in infant-type hemispheric gliomas represent therapeutic targets. 50 supratentorial HGG occurring in children younger than four years were retrieved from the archives of the Brain Tumor Reference Center, Institute of Neuropathology, Bonn University. DNA and RNA were extracted from FFPE tumor samples. Gene fusions were identified on the DNA level by FISH using break-apart probes for ALK, NTRK1, -2, -3, ROS1 and MET and Molecular Inversion Probe (MIP) methodology. On the RNA level, fusion transcripts were detected by targeted RNA sequencing as well as Nanostring assay with fusion-specific probes. 37 supratentorial HGG occurred in the first year of life, 13 HGG between one and four years. 18 cases showed fusions of ALK to different partners; all occurred in the first year of life (18/37, 48.6%). Fusions of ROS1 were found in 5, MET in 3, NTRK1, -2, -3 in 10 cases. 12 cases showed no and two cases novel fusions. The different methods led to comparable results. Only recurrent fusions with known fusion partners were detectable with fusion sequence-specific Nanostring probes and library construction for targeted RNA sequencing failed in a fraction of cases. Break-apart FISH led to reliable results on the next day, and MIP technology represented the most sensitive method for analysis of FFPE samples. Gene fusions involving the tyrosine kinase genes ALK, MET, ROS1 and NTRK1, -2, -3 occurred in 72% of HGG of young children; most frequent were ALK fusions occurring in tumors of infants. DNA-based MIP technology represented the most robust and sensitive assay. A combination of RNA- and DNA-based methods to detect these fusions with high reliability is recommended. |
format | Online Article Text |
id | pubmed-9164882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91648822022-06-05 HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection Pietsch, Torsten Gielen, Gerrit Waha, Andreas Doerner, Evelyn von Bueren, Andre O Vokuhl, Christian Kristiansen, Glen Kramm, Christof Neuro Oncol High Grade Glioma High-grade diffuse gliomas (HGG) in early childhood are characterized by a more favorable outcome compared to older children. We demonstrated in previous studies that these tumors have stable genomes. Activating tyrosine kinase gene fusions in infant-type hemispheric gliomas represent therapeutic targets. 50 supratentorial HGG occurring in children younger than four years were retrieved from the archives of the Brain Tumor Reference Center, Institute of Neuropathology, Bonn University. DNA and RNA were extracted from FFPE tumor samples. Gene fusions were identified on the DNA level by FISH using break-apart probes for ALK, NTRK1, -2, -3, ROS1 and MET and Molecular Inversion Probe (MIP) methodology. On the RNA level, fusion transcripts were detected by targeted RNA sequencing as well as Nanostring assay with fusion-specific probes. 37 supratentorial HGG occurred in the first year of life, 13 HGG between one and four years. 18 cases showed fusions of ALK to different partners; all occurred in the first year of life (18/37, 48.6%). Fusions of ROS1 were found in 5, MET in 3, NTRK1, -2, -3 in 10 cases. 12 cases showed no and two cases novel fusions. The different methods led to comparable results. Only recurrent fusions with known fusion partners were detectable with fusion sequence-specific Nanostring probes and library construction for targeted RNA sequencing failed in a fraction of cases. Break-apart FISH led to reliable results on the next day, and MIP technology represented the most sensitive method for analysis of FFPE samples. Gene fusions involving the tyrosine kinase genes ALK, MET, ROS1 and NTRK1, -2, -3 occurred in 72% of HGG of young children; most frequent were ALK fusions occurring in tumors of infants. DNA-based MIP technology represented the most robust and sensitive assay. A combination of RNA- and DNA-based methods to detect these fusions with high reliability is recommended. Oxford University Press 2022-06-03 /pmc/articles/PMC9164882/ http://dx.doi.org/10.1093/neuonc/noac079.236 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | High Grade Glioma Pietsch, Torsten Gielen, Gerrit Waha, Andreas Doerner, Evelyn von Bueren, Andre O Vokuhl, Christian Kristiansen, Glen Kramm, Christof HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection |
title | HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection |
title_full | HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection |
title_fullStr | HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection |
title_full_unstemmed | HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection |
title_short | HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection |
title_sort | hgg-21. oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of rna- and dna-based methods for their reliable detection |
topic | High Grade Glioma |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164882/ http://dx.doi.org/10.1093/neuonc/noac079.236 |
work_keys_str_mv | AT pietschtorsten hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT gielengerrit hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT wahaandreas hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT doernerevelyn hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT vonbuerenandreo hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT vokuhlchristian hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT kristiansenglen hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection AT krammchristof hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection |